Growth Metrics

Nephros (NEPH) Depreciation & Amortization (CF) (2016 - 2025)

Nephros has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $13000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $13000.0 for Q4 2025, up 8.33% from a year ago — trailing twelve months through Dec 2025 was $55000.0 (up 19.57% YoY), and the annual figure for FY2025 was $55000.0, up 19.57%.
  • Depreciation & Amortization (CF) for Q4 2025 was $13000.0 at Nephros, up from $12000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for NEPH hit a ceiling of $17000.0 in Q1 2022 and a floor of $1000.0 in Q2 2023.
  • Median Depreciation & Amortization (CF) over the past 5 years was $11000.0 (2024), compared with a mean of $9800.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 91.67% in 2023 and later surged 1100.0% in 2024.
  • Nephros' Depreciation & Amortization (CF) stood at $16000.0 in 2021, then crashed by 81.25% to $3000.0 in 2022, then surged by 233.33% to $10000.0 in 2023, then increased by 20.0% to $12000.0 in 2024, then increased by 8.33% to $13000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $13000.0 (Q4 2025), $12000.0 (Q3 2025), and $13000.0 (Q2 2025) per Business Quant data.